blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3900714

EP3900714 - AGENT CONTAINING 4-PHENYLBUTYRATE, FOR PREVENTING OR TREATING PRESBYOPIA [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  24.09.2021
Database last updated on 02.09.2024
FormerThe international publication has been made
Status updated on  02.07.2020
Most recent event   Tooltip22.12.2023New entry: Renewal fee paid 
Applicant(s)For all designated states
Santen Pharmaceutical Co., Ltd.
4-20, Ofuka-cho
Kita-ku
Osaka-shi
Osaka 530-8552 / JP
[2021/43]
Inventor(s)01 / KATO, Masatomo
c/o SANTEN PHARMACEUTICAL CO., LTD., 8916-16,
Takayama-cho
Ikoma-shi, Nara 630-0101 / JP
02 / ODA, Tomoko
c/o SANTEN PHARMACEUTICAL CO., LTD., 8916-16,
Takayama-cho
Ikoma-shi, Nara 630-0101 / JP
03 / NOZAKI, Kensuke
c/o SANTEN PHARMACEUTICAL CO., LTD., 4-20, Ofuka-
cho, Kita-ku
Osaka-shi, Osaka 530-8552 / JP
 [2021/43]
Representative(s)Müller-Boré & Partner Patentanwälte PartG mbB
Friedenheimer Brücke 21
80639 München / DE
[2021/43]
Application number, filing date19897644.117.12.2019
[2021/43]
WO2019JP49354
Priority number, dateJP2018023672418.12.2018         Original published format: JP 2018236724
[2021/43]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020129965
Date:25.06.2020
Language:JA
[2020/26]
Type: A1 Application with search report 
No.:EP3900714
Date:27.10.2021
Language:EN
[2021/43]
Search report(s)International search report - published on:JP25.06.2020
(Supplementary) European search report - dispatched on:EP23.08.2022
ClassificationIPC:A61K31/192, A61P27/10, A61K9/06, A61K9/08, A61K47/02, A61K47/14, A61K47/38
[2021/43]
CPC:
A61K9/0048 (EP,KR,US); A61K31/192 (EP,KR,US); A61K47/02 (EP,KR);
A61K47/14 (EP,KR); A61K47/38 (EP,KR); A61K9/06 (EP,KR);
A61K9/08 (EP); A61P27/02 (KR); A61P27/10 (EP,KR,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/43]
TitleGerman:4-PHENYLBUTYRAT ENTHALTENDES MITTEL ZUR VORBEUGUNG ODER BEHANDLUNG VON PRESBYOPIE[2021/43]
English:AGENT CONTAINING 4-PHENYLBUTYRATE, FOR PREVENTING OR TREATING PRESBYOPIA[2021/43]
French:AGENT CONTENANT DU 4-PHÉNYLBUTYRATE, POUR LA PRÉVENTION OU LE TRAITEMENT DE LA PRESBYTIE[2021/43]
Entry into regional phase15.06.2021Translation filed 
17.06.2021National basic fee paid 
17.06.2021Search fee paid 
17.06.2021Designation fee(s) paid 
17.06.2021Examination fee paid 
Examination procedure17.06.2021Examination requested  [2021/43]
16.03.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
15.12.2021Renewal fee patent year 03
13.12.2022Renewal fee patent year 04
21.12.2023Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]WO2004058289  (CHAKSHU RES INC [US]) [Y] 1-10* paragraph [0066]; example 1; claims 1,7,59,60,62,64,71 *;
 [Y]US2010317608  (GARNER WILLIAM [US], et al) [Y] 1-10 * paragraph [0005] *;
 [XY]JP2016515575  (AMYLYX PHARMACEUTICALS) [X] 1-5,9,10 * paragraph [0008] - paragraph [0009]; claim - * [Y] 6-8;
 [XY]US9480673  (FREED CURT R [US], et al) [X] 1-5,10 * column 14, line 49 - line 55; column 8, line 16 - line 18 * [Y] 6-9;
 [X]WO2018164113  (UNIV KEIO [JP]) [X] 1-10 * figure 4; example 1; claim - *;
 [Y]CN108904696  (GUANGZHOU BAIJITANG CHINESE MEDICINE RES CENTER) [Y] 1-10 * "Background technique" *
International search[Y]JP2005506096  [Y] 1-10;
 [Y]JP2013527222  [Y] 1-10;
 [Y]JP2016515575  [Y] 1-10;
 [Y]WO2018030389  (UNIV KEIO [JP]) [Y] 1-10;
 [A]WO2018164113  (UNIV KEIO [JP])[A] 1-10;
 [Y]  - AKIHIRO HIGUCHI ET AL., "Research for the Prevention and Treatment of Presbyopia", journal of the eye, Medical Aoi publication, JP, JP, (20141030), vol. 31, no. 10, ISSN 0910-1810, pages 1443 - 1448, XP009502671 [Y] 1-10
by applicantWO2010147957
    - Atarashii ganka'' [A New Ophthalmology, (20110000), vol. 28, no. 7, pages 985 - 988
    - InvestOphthalmol Vis Sci, (20160000), vol. 57, pages 2851 - 2863
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.